WallStreetZenWallStreetZen

NASDAQ: SWTX
Springworks Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

SWTX past revenue growth

How has SWTX's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
SWTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SWTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

SWTX earnings and revenue history

Current Revenue
$5.4M
Current Earnings
-$325.1M
Current Profit Margin
-5,968.5%

SWTX Return on Equity

Current Company
-65.7%
Current Industry
-63.5%
Current Market
188%
SWTX's Return on Equity (-65.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SWTX announces earnings.

SWTX Return on Assets

Current Company
-57%
Current Industry
2.9%
SWTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SWTX Return on Capital Employed

Current Company
-50.2%
Current Industry
19.5%
SWTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SWTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SWTX$5.45M-$321.78M-$325.10M-94.52%N/A
AXSM$270.60M-$223.54M-$239.24M+440.80%N/A
IOVA$1.19M-$414.39M-$444.04MN/AN/A
FTRE$3.11B$194.70M-$3.40M+58.95%N/A
BHVN$0.00-$402.64M-$408.17MN/AN/A
View Top Biotech Stocks

SWTX earnings dates

Next earnings date
May 16, 2024

Springworks Therapeutics Earnings & Revenue FAQ

What were SWTX's earnings last quarter?

On Invalid Date, Springworks Therapeutics (NASDAQ: SWTX) reported Q4 2023 earnings per share (EPS) of -$1.45, up 23.93% year over year. Total Springworks Therapeutics earnings for the quarter were -$94.32 million. In the same quarter last year, Springworks Therapeutics's earnings per share (EPS) was -$1.17.

If you're new to stock investing, here's how to buy Springworks Therapeutics stock.

What was SWTX's earnings growth in the past year?

As of Q2 2024, Springworks Therapeutics's earnings has grown year over year. Springworks Therapeutics's earnings in the past year totalled -$325.10 million.

What is SWTX's earnings date?

Springworks Therapeutics's earnings date is Invalid Date. Add SWTX to your watchlist to be reminded of SWTX's next earnings announcement.

What was SWTX's revenue last quarter?

On Invalid Date, Springworks Therapeutics (NASDAQ: SWTX) reported Q4 2023 revenue of $5.45 million up Infinity% year over year. In the same quarter last year, Springworks Therapeutics's revenue was $0.00.

What was SWTX's revenue growth in the past year?

As of Q2 2024, Springworks Therapeutics's revenue has grown null year over year. Springworks Therapeutics's revenue in the past year totalled $5.45 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.